{"id":10300,"date":"2021-01-19T21:05:00","date_gmt":"2021-01-20T03:05:00","guid":{"rendered":"https:\/\/shockwavemedical.com\/news\/shockwave-medical-to-report-fourth-quarter-and-full-year-2020-financial-results-on-february-17-2021\/"},"modified":"2021-01-19T21:05:00","modified_gmt":"2021-01-20T03:05:00","slug":"shockwave-medical-to-report-fourth-quarter-and-full-year-2020-financial-results-on-february-17-2021","status":"publish","type":"news","link":"https:\/\/shockwavemedical.com\/en-eu\/news\/shockwave-medical-to-report-fourth-quarter-and-full-year-2020-financial-results-on-february-17-2021\/","title":{"rendered":"Shockwave Medical to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021"},"content":{"rendered":"\n<section id=\"block_e05da5b2212a93a72d15e444fd716dad\" class=\"block block--wysiwyg wysiwyg_styles u-bgColorNone container\">\n\t<div class=\"u-wysiwyg u-animation\">\n\t\t<p align=\"left\">SANTA CLARA, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) \u2014 Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced it will report financial results for the fourth quarter and full year 2020 after market close on Wednesday, February 17, 2021. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time.<\/p>\n<p>Investors interested in listening to the conference call may do so by dialing (866) 795-9106 for domestic callers or (470) 495-9173 for international callers, using conference ID: 7854854.<\/p>\n<p><strong>About Shockwave Medical, Inc.<\/strong><br \/>\nShockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IIKzonEVRwOxRCjoX1M7OiEfUCg70EwWdSM9_2VKmZAdjyoiCgpzAqePzelVRhq_4qlb5nVl7UVi5sytufEsnalSSKU1f5OPGdXzu8HyEQs=\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">www.shockwavemedical.com<\/a>.<\/p>\n<p><strong>Media Contact:<br \/>\n<\/strong>Scott Shadiow<br \/>\n+1.317.432.9210<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5eWPU8bsawgglPADzqQaFkVhxKD51NQ0OPRi8rpIvPY8eDgpbkiwbUOnmzMFbv7Mr8ulUp5Q56YhBhfmjH4l6em4h70KFURnqivX9PfEZNobOVmMKzLevBIzgSsj-GDo\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">sshadiow@shockwavemedical.com<\/a><\/p>\n<p><strong>Investor Contact:<br \/>\n<\/strong>Debbie Kaster<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KI2Bi2Cr13ZhbiW-apAGsMq7uUOjB7IgIZmFxXaLaFkaG87KVSBg9WIj0f1KhygEMVXbztjLtZ_EFQiAXBu00jHprsCjTIuncDH5dho25sECh911RcSKtDN4v2iMfXOy\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">dkaster@shockwavemedical.com<\/a><\/p>\n<p>\u00a0<\/p>\n\t<\/div>\n\t<\/section>","protected":false},"excerpt":{"rendered":"<p>Shockwave Medical announced it will report financial results for the fourth quarter and full year 2020 after market close on Wednesday, February 17, 2021.<\/p>\n","protected":false},"featured_media":9942,"template":"","format":[],"meta":{"_acf_changed":true,"content-type":""},"disease-state":[],"news-topic":[],"product-tag":[],"specialty":[],"technology":[],"class_list":["post-10300","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/news\/10300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/media\/9942"}],"wp:attachment":[{"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/media?parent=10300"}],"wp:term":[{"taxonomy":"disease-state","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/disease-state?post=10300"},{"taxonomy":"format","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/format?post=10300"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/news-topic?post=10300"},{"taxonomy":"product-tag","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/product-tag?post=10300"},{"taxonomy":"specialty","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/specialty?post=10300"},{"taxonomy":"technology","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/technology?post=10300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}